Is humoral and cellular response to SARS-CoV-2 vaccine modified by DMT in patients with multiple sclerosis and other autoimmune diseases?

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 7, p. 1138, doi. 10.1177/13524585221089540

By:

• Zabalza, Ana;
• Arrambide, Georgina;
• Otero-Romero, Susana;
• Pappolla, Agustín;
• Tagliani, Paula;
• López-Maza, Samuel;
• Cárdenas-Robledo, Simón;
• Esperalba, Juliana;
• Fernández-Naval, Candela;
• Martínez-Gallo, Monica;
• Castillo, Mireia;
• Bonastre, Mercè;
• Resina-Salles, Mireia;
• Bertran, Jordina;
• Rodriguez-Barranco, Marta;
• Carbonell-Mirabent, Pere;
• Gonzalez, Marina;
• Merchan, Miguel;
• Quiroga-Varela, Ana;
• Miguela, Albert

Publication type:

Article